Ethema Health Corporation (GRST)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 16, 2026, 4:00 PM EST
Ethema Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0 | 4 | 5 | 1 | 1 | 4 | |
Market Cap Growth | -99.75% | -28.60% | 383.62% | -25.00% | -58.32% | -49.55% |
Enterprise Value | 32 | 36 | 23 | 16 | 13 | 17 |
Last Close Price | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 0.99 | 9.94 | - |
PS Ratio | 0.00 | 0.21 | 0.90 | 0.21 | 0.31 | 1.84 |
PB Ratio | 0.00 | -0.40 | -0.72 | -0.18 | -0.17 | -0.38 |
P/FCF Ratio | - | - | - | - | 1.18 | - |
P/OCF Ratio | - | - | - | - | 0.95 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.70 | 1.90 | 3.75 | 2.93 | 2.79 | 8.54 |
EV/EBITDA Ratio | 5.68 | 13.77 | - | - | 13.09 | 50.65 |
EV/EBIT Ratio | 17.86 | 20.04 | - | - | 27.54 | 7879.28 |
EV/FCF Ratio | - | - | - | - | 10.68 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | -3.30 | -3.30 | -2.31 | -2.35 | -1.29 | -1.22 |
Debt / EBITDA Ratio | 5.68 | 5.68 | 39.36 | 25.50 | 7.85 | 22.73 |
Debt / FCF Ratio | - | - | - | - | 9.07 | - |
Net Debt / Equity Ratio | -3.30 | -3.30 | -2.28 | -2.34 | -1.28 | -1.21 |
Net Debt / EBITDA Ratio | 12.25 | 12.25 | -19.62 | -337.54 | 10.97 | 34.98 |
Net Debt / FCF Ratio | -102.34 | -102.34 | -22.48 | -2.51 | 8.95 | -52.45 |
Asset Turnover | 0.92 | 0.92 | 0.51 | 0.59 | 0.74 | 0.37 |
Quick Ratio | 0.10 | 0.10 | 0.05 | 0.05 | 0.04 | 0.02 |
Current Ratio | 0.10 | 0.10 | 0.06 | 0.05 | 0.04 | 0.02 |
Return on Assets (ROA) | 5.45% | 5.45% | -7.04% | -3.75% | 4.66% | 0.03% |
Return on Invested Capital (ROIC) | 12.33% | 22.41% | -46.58% | - | - | - |
Return on Capital Employed (ROCE) | 13.30% | 13.30% | -53.20% | -16.80% | -7.30% | 0.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -28186.24% | -56.37% | -38.15% | 105.17% | 16.62% | -43.11% |
FCF Yield | -4020.40% | -8.04% | -13.97% | -516.67% | 84.56% | -6.10% |
Buyback Yield / Dilution | -37.76% | -37.76% | -50.41% | -0.65% | -37.13% | -32.08% |